Agata Zieba

4A Chodzki St
Lublin, LU 20059, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

SERAAK2 as a Serotonin Receptor Ligand: Structural and Pharmacological In Vitro and In Vivo Evaluation.

SERAAK2 as a Serotonin Receptor Ligand: Structural and Pharmacological In Vitro and In Vivo Evaluation.

Journal: Molecules (Basel, Switzerland)

Published: October 13, 2025

Novel 1,4-benzothiazepin-2-one modulators of NCX3 as a promising strategy for neuroprotection in cerebral ischemia.

Novel 1,4-benzothiazepin-2-one modulators of NCX3 as a promising strategy for neuroprotection in cerebral ischemia.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 20, 2025

Synthesis, Experimental and Computational Evaluation of SERAAK1 as a 5-HT2A Receptor Ligand.

Synthesis, Experimental and Computational Evaluation of SERAAK1 as a 5-HT2A Receptor Ligand.

Journal: Molecules (Basel, Switzerland)

Published: March 26, 2025

Sampling and Scoring in Protein-Protein Docking.

Sampling and Scoring in Protein-Protein Docking.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 10, 2024

Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening.

Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening.

Journal: ChemMedChem

Published: January 26, 2024

The application of WaterMap-guided structure-based virtual screening in novel drug discovery.

The application of WaterMap-guided structure-based virtual screening in novel drug discovery.

Journal: Expert opinion on drug discovery

Published: October 09, 2023

Caspases in Alzheimer's Disease: Mechanism of Activation, Role, and Potential Treatment.

Caspases in Alzheimer's Disease: Mechanism of Activation, Role, and Potential Treatment.

Journal: Molecular neurobiology

Published: September 22, 2023

Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation.

Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: May 15, 2023

Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia.

Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia.

Journal: Molecules (Basel, Switzerland)

Published: April 30, 2023

The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery.

The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery.

Journal: International journal of molecular sciences

Published: December 23, 2022

Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents - Design, synthesis, structural studies and pharmacological profiling.

Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents - Design, synthesis, structural studies and pharmacological profiling.

Journal: European journal of medicinal chemistry

Published: December 23, 2022

What are the challenges with multi-targeted drug design for complex diseases?

What are the challenges with multi-targeted drug design for complex diseases?

Journal: Expert opinion on drug discovery

Published: May 13, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026